Clivatuzumab MMAE Antibody
Clivatuzumab MMAE is an antibody-drug conjugate (ADC) targeting MUC1 for pancreatic cancer research, delivering the cytotoxic agent MMAE. It is utilized in both in vitro cell-based assays and in vivo xenograft studies to investigate targeted therapy efficacy and mechanisms.
Product Specifications
Product Name Alternative
Anti-MUC1 Reference Antibody
Target
Antibody-Drug Conjugates (ADCs), Mucin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
9.36 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.42 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV677675 1.0 µg DNA
CAPN3 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details GTR10411691 96 Well
Rat Collagen Alpha 2 (V) chain (COL5A2) ELISA kit
Sign In for Pricing
View Details 
orb3116859 100 µg
H-ERG/KCNH2/ERG Rabbit Polyclonal Antibody (Fluoro550)
Sign In for Pricing
View Details